Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000724721 | SCV000230217 | uncertain significance | not provided | 2017-06-08 | criteria provided, single submitter | clinical testing | |
Genomic Diagnostic Laboratory, |
RCV000203047 | SCV000257942 | benign | not specified | 2015-05-05 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001087290 | SCV001021231 | likely benign | Septo-optic dysplasia sequence; GROWTH HORMONE DEFICIENCY WITH PITUITARY ANOMALIES | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001147432 | SCV001308256 | uncertain significance | Septo-optic dysplasia sequence | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Ce |
RCV000724721 | SCV004150364 | likely benign | not provided | 2023-07-01 | criteria provided, single submitter | clinical testing | HESX1: BP4, BP7 |
Laboratory of Diagnostic Genome Analysis, |
RCV000724721 | SCV001798591 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000203047 | SCV001923689 | benign | not specified | no assertion criteria provided | clinical testing |